Europe — EMA

Oxaliplatino Hikma

Oxaliplatin, the active ingredient in Oxaliplatino Hikma, is a platinum‑based chemotherapy presented as a sterile powder for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatino Hikma, is a platinum‑based chemotherapy presented as a sterile powder for intravenous infusion use. It treats colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxaliplatino Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatino Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin is an alkylating agent that interferes

- Colorectal cancer: It ... … … ... … ... ... … … … … … … … … - ... .... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →